JFNIX

Janus Henderson Global Life Sciences Fund Class I [JFNIX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JFNIX Stock Summary

Top 10 Correlated ETFs

JFNIX

Top 10 Correlated Stocks

JFNIX

In the News

JFNIX Financial details

Company Rating
-
Market Cap
0
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
1.98%
SMA50
4.28%
SMA100
18.77%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
62.13-75.75
52W High
+9%
52W Low
+31.85%
RSI
46.99
Rel Volume
-
Avg Volume
-
Volume
Perf Week
-0.57%
Perf Month
1.58%
Perf Quarter
24.39%
Perf Half Y
22.34%
-
-
-
-
Beta
0.72
-
-
Volatility
0.62%, 1.02%
Prev Close
-1.27%
Price
81.75
Change
-1.27%

JFNIX Financial Performance

JFNIX Dividend History

JFNIX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class I stock symbol ?

Janus Henderson Global Life Sciences Fund Class I is a US stock and trading under the symbol JFNIX

What is Janus Henderson Global Life Sciences Fund Class I stock quote today ?

Janus Henderson Global Life Sciences Fund Class I stock price is $81.75 today.

Is Janus Henderson Global Life Sciences Fund Class I stock public?

Yes, Janus Henderson Global Life Sciences Fund Class I is a publicly traded company.

Something similar

Top by Market Cap
CMC.DE
VFINX
APC.DE
0YXG.L
MSFT
Top Correlated ETFs
BMED
PPH
FTXH
MEDI
IXJ
Top Correlated Stocks
SHSKX
SHSCX
SHSSX
SHISX
BHSRX
Similar Market Cap
ANX.TO
MCMVX
SUIC
FCNCB
EMUS.DE

Company Profile

Financial Services Asset Management - Global
  • Headquarters US
  • IPO Date 2009-07-06

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.